Orgenesis, Inc.
Orgenesis Inc. is dedicated to unlocking the potential of cell and gene therapies (CGTs) by providing affordable and accessible solutions. The company focuses on overcoming the challenges of processing personalized CGTs locally to impact patients globally. Through its POCare Platform, Orgenesis aims to lower costs and standardize high-quality CGTs, making advanced therapies more accessible to patients worldwide.
Industries
Nr. of Employees
medium (51-250)
Orgenesis, Inc.
Products
Mobile integrated closed-loop bioprocessing unit
A fully integrated, mobile processing unit that provides a standardized closed processing environment for onsite production of cell and gene therapies.
Validated automated processing systems for cell therapies
Customized automated processing platforms validated for specific therapies to enable scalable, GMP-compliant production at the point of care.
Decentralized manufacturing platform for CGTs
A harmonized network and operational model combining standardized processing units, QA systems, supply chains and data management to support distributed production of advanced therapies.
Mobile integrated closed-loop bioprocessing unit
A fully integrated, mobile processing unit that provides a standardized closed processing environment for onsite production of cell and gene therapies.
Validated automated processing systems for cell therapies
Customized automated processing platforms validated for specific therapies to enable scalable, GMP-compliant production at the point of care.
Decentralized manufacturing platform for CGTs
A harmonized network and operational model combining standardized processing units, QA systems, supply chains and data management to support distributed production of advanced therapies.
Services
POCare platform deployment and point-of-care center implementation
Design and deployment of regional point-of-care centers that host standardized processing units, harmonized QA, centralized data and unified supply chains to enable onsite therapy production.
Mobile integrated bioprocessing unit engineering
Provision and customization of mobile, closed-loop bioprocessing units for CGT manufacture including mechanical design, containment systems, and site commissioning.
Process development, automation integration and GMP validation
Process development services focused on automated processing, QC integration and GMP/cGMP validation to enable clinical and commercial manufacturing.
Network partnership for clinical research and licensing
Collaboration with hospitals, academia and industry partners to conduct clinical research, validate therapies onsite and license validated therapies for point-of-care production.
POCare platform deployment and point-of-care center implementation
Design and deployment of regional point-of-care centers that host standardized processing units, harmonized QA, centralized data and unified supply chains to enable onsite therapy production.
Mobile integrated bioprocessing unit engineering
Provision and customization of mobile, closed-loop bioprocessing units for CGT manufacture including mechanical design, containment systems, and site commissioning.
Process development, automation integration and GMP validation
Process development services focused on automated processing, QC integration and GMP/cGMP validation to enable clinical and commercial manufacturing.
Network partnership for clinical research and licensing
Collaboration with hospitals, academia and industry partners to conduct clinical research, validate therapies onsite and license validated therapies for point-of-care production.
Expertise Areas
- Cell and gene therapy manufacturing
- Decentralized point-of-care manufacturing
- GMP-compliant process development and validation
- Automated bioprocessing and sensor integration
Key Technologies
- Closed-system bioprocessing units (bio-isolator)
- Mobile modular processing units
- Automated single-use sensors
- Cloud-based batch monitoring and traceability